Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-075906
Filing Date
2021-06-02
Accepted
2021-06-02 19:16:34
Documents
1
Period of Report
2021-06-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2118270-7_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2118270-7_4seq1.xml 4 4024
  Complete submission text file 0001104659-21-075906.txt   5384
Mailing Address 18 CHERRYVILLE RD FLEMINGTON NJ 08822
Business Address
KISHBAUCH MICHAEL D (Reporting) CIK: 0001076979 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 21990794

Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations